JP2010531846A5 - - Google Patents

Download PDF

Info

Publication number
JP2010531846A5
JP2010531846A5 JP2010513952A JP2010513952A JP2010531846A5 JP 2010531846 A5 JP2010531846 A5 JP 2010531846A5 JP 2010513952 A JP2010513952 A JP 2010513952A JP 2010513952 A JP2010513952 A JP 2010513952A JP 2010531846 A5 JP2010531846 A5 JP 2010531846A5
Authority
JP
Japan
Prior art keywords
antibody
binding fragment
fragment
antagonist
receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010513952A
Other languages
English (en)
Japanese (ja)
Other versions
JP5554703B2 (ja
JP2010531846A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2008/058339 external-priority patent/WO2009000929A2/en
Publication of JP2010531846A publication Critical patent/JP2010531846A/ja
Publication of JP2010531846A5 publication Critical patent/JP2010531846A5/ja
Application granted granted Critical
Publication of JP5554703B2 publication Critical patent/JP5554703B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010513952A 2007-06-28 2008-06-27 自己免疫疾患の治療のための組成物および方法 Active JP5554703B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
IE20070468 2007-06-28
IE2007/0468 2007-06-28
US3837208P 2008-03-20 2008-03-20
IE2008/0209 2008-03-20
US61/038,372 2008-03-20
IE20080209 2008-03-20
PCT/EP2008/058339 WO2009000929A2 (en) 2007-06-28 2008-06-27 Composition and method for treatment of autoimmune disease

Publications (3)

Publication Number Publication Date
JP2010531846A JP2010531846A (ja) 2010-09-30
JP2010531846A5 true JP2010531846A5 (https=) 2011-08-04
JP5554703B2 JP5554703B2 (ja) 2014-07-23

Family

ID=39758798

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010513952A Active JP5554703B2 (ja) 2007-06-28 2008-06-27 自己免疫疾患の治療のための組成物および方法

Country Status (7)

Country Link
US (1) US8580255B2 (https=)
EP (1) EP2170392A2 (https=)
JP (1) JP5554703B2 (https=)
CN (1) CN101808662A (https=)
AU (1) AU2008267151B2 (https=)
CA (1) CA2691784C (https=)
WO (1) WO2009000929A2 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100278817A1 (en) * 2007-07-05 2010-11-04 Opsona Therapeutics Ltd. Compounds and methods for the treatment of renal disease
WO2011156451A2 (en) * 2010-06-08 2011-12-15 The Cleveland Clinic Foundation Compositions and methods for modulating toll-like receptor 2 activation
US9981018B2 (en) 2010-06-08 2018-05-29 The Cleveland Clinic Foundation Compositions and methods for modulating toll-like receptor 2 activation
US9890202B2 (en) * 2010-07-19 2018-02-13 Yeda Research And Development Co. Ltd. Peptides based on the transmembrane domain of a toll-like receptor (TLR) for treatment of TLR-mediated diseases
CA2828544A1 (en) 2011-03-03 2012-09-07 Quark Pharmaceuticals, Inc. Oligonucleotide modulators of the toll-like receptor pathway
US9796979B2 (en) 2011-03-03 2017-10-24 Quark Pharmaceuticals Inc. Oligonucleotide modulators of the toll-like receptor pathway
WO2014144686A1 (en) * 2013-03-15 2014-09-18 University Of Florida Research Foundation Compunds for treating neurodegenerative proteinopathies
US10118942B2 (en) 2015-03-26 2018-11-06 H. Lee Moffitt Cancer Center And Research Institute, Inc. Toll-like receptor 2 ligands and methods of making and using thereof
HK1250955A1 (zh) * 2015-06-15 2019-01-18 生命治疗有限公司 用於诱导抗炎反应的组合物和方法
KR20200134212A (ko) * 2018-01-02 2020-12-01 러쉬 유니버시티 메디컬 센터 신경계 장애 및 기타 장애를 치료하기 위한 조성물 및 방법
WO2020011869A2 (en) 2018-07-11 2020-01-16 Roche Innovation Center Copenhagen A/S Antisense oligonucleotides targeting tlr2

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9927332D0 (en) * 1999-11-18 2000-01-12 Leiv Eiriksson Nyfotek As Novel antibody and uses thereof
US7388080B2 (en) * 2003-08-20 2008-06-17 University Of Massachusetts Selective inhibition of toll-like receptor-2
ATE510853T1 (de) * 2003-09-23 2011-06-15 Univ Muenchen Tech Tlr2-antagonistischer antikörper und dessen verwendung
US7202234B2 (en) * 2003-10-24 2007-04-10 Eisai Co., Ltd. Compounds and methods for treating Toll-like receptor 2-related diseases and conditions
WO2005079419A2 (en) * 2004-02-17 2005-09-01 The Regents Of The University Of California Methods of treating immunopathological disorders
PT1830881E (pt) * 2004-12-10 2010-08-30 Novimmune Sa Terapias de combinação visando múltiplos receptores do tipo toll e a sua utilização
GT200600065A (es) 2005-02-14 2006-10-02 Anticuerpos para interleucina-17f y otros antagonistas de la señalizacion de il-17f y sus usos
WO2008132516A1 (en) * 2007-04-26 2008-11-06 Opsona Therapeutics Limited Toll-like receptor binding epitope and compositions for binding thereto

Similar Documents

Publication Publication Date Title
JP2010531846A5 (https=)
Chu et al. Reduction of total IgE by targeted coengagement of IgE B-cell receptor and FcγRIIb with Fc-engineered antibody
ES2514495T3 (es) Anticuerpos humanizados modificados anti-interleucina-18
HRP20191341T1 (hr) Protutijela koja vežu ljudski cgrp receptor
Shaw et al. Discovery and characterization of olokizumab: a humanized antibody targeting interleukin-6 and neutralizing gp130-signaling
TWI687440B (zh) Ｓｔ２ｌ拮抗劑及使用方法
HRP20231031T1 (hr) Protutijela protiv sars-cov-2
FI3592384T3 (fi) Vasta-aineita, jotka spesifisesti sitoutuvat ihmisen IL-1R7:ään
JP2015535820A5 (https=)
US10618957B2 (en) Antibody molecules which bind CD79
JP2022031635A5 (https=)
HRP20191342T1 (hr) Anti-phf-tau antitijela i njihove upotrebe
JP2019214582A (ja) Ｃｄ３／ｃｄ３８ ｔ細胞再標的化ヘテロ二量体免疫グロブリン及びその製造方法
JP2012516158A5 (https=)
JP2012501670A5 (https=)
HRP20171080T1 (hr) Protutijela s modificiranim affinitetom za fcrn koja potiču uklanjanje antigena
JP2017522043A5 (https=)
JP2012531922A5 (ja) Ｔｏｌｌ様受容体２へのヒト化抗体またはその抗原結合部位
CA2992372A1 (en) Antibody molecules which bind cd22
EA201001467A1 (ru) Моноклональное антитело и способ его использования
JP2015501291A5 (https=)
JP6009431B2 (ja) アフィニティー精製の方法
WO2016009030A2 (en) Molecules with specificity for cd79 and cd22
CN103145838A (zh) Il-12/p40结合蛋白
HRP20221260T1 (hr) Humanizirana i kimerna monoklonska protutijela za cd47